par value $0.01 per share) Controlled Equity OfferingSM Sales AgreementNewlink Genetics Corp • March 13th, 2018 • Pharmaceutical preparations • New York
NewLink Genetics Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
